Evaluation of antidiabetic activity of Oxalis corniculata in streptozotocin induced diabetic rats
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20163258Keywords:
Antidiabetic, Oxalis corniculata, StreptozotocinAbstract
Background: Oxalis corniculata is traditionally well known for its versatile uses. The present study was carried out to evaluate the antidiabetic action of ethanolic extract of Oxalis corniculata in streptozotocin induced diabetic albino rats.
Methods: To look for the antidiabetic effect the albino rats were divided into 5 groups, each consisting of 6 animals. Diabetes was induced by a single i.p. injection of streptozotocin at a dose of 50mg/kg body weight. Standard drug, glibenclamide and ethanolic extract of Oxalis corniculata (EEOC) at doses 200mg/kg and 400mg/kg body weight was fed to the rats and it was continued till the end of the study. The blood glucose levels were estimated on day 0, 3, 7, 14 and 21 day. The standard drug and the extract were fed from day 4 onwards.
Results: The antidiabetic property of the extract has shown increasing trend with increase in dose and there was a gradual decrease in blood glucose levels with increased period of exposure to the test drug.
Conclusions: Results obtained in this study substantiate the anti-diabetic activity of EEOC leaves.
References
American Diabetes Association. Position Statement: Diagnosis and Classification of Diabetes Mellitus. Diabetes care.2010;33(1):562-69.
Powers AC. Diabetes mellitus. Kasper DL, Braunwald E., Fauci AS, Hauser SL, Longo DL, Jameson JL. Harrison’s Principles of Internal Medicine. NewYork: Mc Graw Hill. 2012;18(2):2968-3003.
Ramachandran A, Snehalatha C, Viswanathan V. Burden of type 2 diabetes and its complications- the Indian scenario. Current Sci. 2002;83(12):1471-6.
Thevenod F. Pathophysiology of diabetes mellitus type 2: roles of obesity, insulin resistance and β-cell dysfunction. diabetes and cancer epidemiological evidence and molecular links. front diabetes. Basel, Karger. 2008;19:1-18.
Mohan V, Sandeep S, Deepa R, Shah B, Varghese B. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007;125:217-30.
Porter DJ, Raymond LW, Anastasio GD. Chromium, Friend or foe. Archives of Family Medicine.1999;8(5):386-90.
Taranalli AD, Tipare SV, Torgal SS, Kumar S. Wound healing activity of Oxalis corniculata whole plant extract in rats. Indian J Pharmacology. 2004;66:444-46.
Achola KJ, Mwangi JW, Munenge RW. Pharmacological activity of Oxalis corniculata. Pharmaceutical Biology. 1995;33:247-49.
Kathiriya A, Das K, Kumar EP, Mathai KB. Evaluation of antitumor and antioxidant activity of Oxalis corniculata linn. Against Ehrlich ascites carcinoma on mice, Iranian Journal of Cancer Prevention. 2010;4:157-65.
Raghvendra MP, Satish S. Raveesha KA. Phytochemical analysis and antibacterial activity of Oxalis corniculata, a known medicinal plant. Science. 2006;1:72-8.
Verma RK, Chaurasia L, Katiyar S. Potential antifungal plants for controlling building fungi. Natural Product Radiance. 2008;7(4):374-87.
Sharangouda K, Patil SB. Antiimplantation and abortifacient activities of Oxalis corniculata in albino rats. Nigerian Journal of Natural Products and Medicine. 2007;11:58-60.
Babu PS, Mainzen S, Prince P. Antihyperglycaemic and antioxidant effect of hyponidd, an ayurvedic herbomineral formulation in streptozotocin induced diabetic rats. J. Pharm Pharmacol. 2004;56(11):1435-42.
Pascoe WS, Storlien LH. Inducement by feeding of basal hyperglycemia in rats with abnormal β-cell function. Diabetes. 1990;39:226-33.
Ilham S, Ali MS, Hasan CM, Kaisar MA, Bachar SC. Antinociceptive and hypoglycemic activity of methanolic extract of Phlogacanthus thyrsiflorus. Asian Journal of Pharmaceutical and Clinical Research. 2012;5(2):15-8.
Chau CF, Wu SH. The development of regulations of Chinese herbal medicines for both medicinal and food uses. Trends in Food Sciences and Technology. 2006;17:313-23.
Patwardhan B, Vaidya ADB, Chorghade M. Ayurveda and natural products drug discovery. Current Science. 2004;86:789-99.
Mahalingam G, Krishnan K. Antidiabetic and ameliorative potential of Ficus bengalensis bark extract in streptozotocin induced diabetic rats. Indian Journal of Clinical Biochemistry. 2008;23(4):394-400.
Ghosh MN. Chapter1.Common laboratory animals. Fundamentals of experimental pharmacology. Kolkata: Hilton and Company. 2008;1-14.
Agila KN, Kavitha R. Antidiabetic, antihyperlipidaemic and antioxidant activity of Oxalis corniculata in alloxan induced diabetic mice. Journal of Natural Sciences Research. 2012;2(7):9-17.
Prato DS, Pulizzi N. The place of sulphonylureas in the therapy for type 2 diabetes mellitus. Metabolism. 2006;55:20-7.
Srikanth M, Tadigotla S, Veeresh B. Phytochemistry and pharmacology of Oxalis corniculata linn: a review. International Journal of Pharmaceutical Sciences and Research. 2012;3(11):4077-85.
Soud ENA, Khalil MY, Hussain JS, Oraby FH, Farrag AH. Antidiabetic effects of fenugreek alkaloid extract in streptozotocin induced hyperglycaemic rats. Journal of Applied Sciences Research. 2007;3(10):1073-83.
Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, Umayahara Y et al. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic β cells against glucose toxicity. Diabetes. 1999;48:2398-406.
Sachan NK, Kumar Y, Pushkar S, Thakur RN, Gangwar SS, Kalaichelvan VK. Antidiabetic potential of alcoholic and aqueous extracts of Ficus Racemosa Linn. bark in normal and alloxan induced diabetic rats. International Journal of Pharmaceutical Sciences and Drug Research. 2009;1(1):24-7.
